These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 23242220)
1. Analysis of the culture-derived soluble Babesia canis canis antigens derived from the Polish strains of the parasites. Adaszek L; Puchalski A; Dec M; Winiarczyk S Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012; 40(6):399-403. PubMed ID: 23242220 [TBL] [Abstract][Full Text] [Related]
2. Discovery of a recombinant Babesia canis supernatant antigen that protects dogs against virulent challenge infection. Moubri K; Kleuskens J; Van de Crommert J; Scholtes N; Van Kasteren T; Delbecq S; Carcy B; Précigout E; Gorenflot A; Schetters T Vet Parasitol; 2018 Jan; 249():21-29. PubMed ID: 29279083 [TBL] [Abstract][Full Text] [Related]
3. Vaccination of dogs against heterologous Babesia canis infection using antigens from culture supernatants. Schetters TP; Kleuskens JA; Scholtes NC; Gorenflot A; Moubri K; Vermeulen AN Vet Parasitol; 2001 Sep; 100(1-2):75-86. PubMed ID: 11522408 [TBL] [Abstract][Full Text] [Related]
4. Vaccination against canine babesiosis. Schetters T Trends Parasitol; 2005 Apr; 21(4):179-84. PubMed ID: 15780840 [TBL] [Abstract][Full Text] [Related]
5. Onset and duration of immunity against Babesia canis infection in dogs vaccinated with antigens from culture supernatants. Schetters TP; Kleuskens JA; Scholtes NC; van de Crommert J; Krijnen E; Moubri K; Gorenflot A; Vermeulen AN Vet Parasitol; 2006 May; 138(1-2):140-6. PubMed ID: 16504401 [TBL] [Abstract][Full Text] [Related]
6. Not peripheral parasitaemia but the level of soluble parasite antigen in plasma correlates with vaccine efficacy against Babesia canis. Schetters TP; Scholtes NC; Kleuskens JA; Bos HJ Parasite Immunol; 1996 Jan; 18(1):1-6. PubMed ID: 9223150 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Babesia rossi and Babesia canis isolates with emphasis on effects of vaccination with soluble parasite antigens: a review. Schetters TP; Moubri K; Cooke BM J S Afr Vet Assoc; 2009 Jun; 80(2):75-8. PubMed ID: 19831266 [TBL] [Abstract][Full Text] [Related]
8. Immunity against Babesia rossi infection in dogs vaccinated with antigens from culture supernatants. Schetters TP; Strydom T; Crafford D; Kleuskens JA; van de Crommert J; Vermeulen AN Vet Parasitol; 2007 Mar; 144(1-2):10-9. PubMed ID: 17056181 [TBL] [Abstract][Full Text] [Related]
10. Vaccination against large Babesia species from dogs. Schetters TP; Kleuskens J; Carcy B; Gorenflot A; Vermeulen A Parassitologia; 2007 May; 49 Suppl 1():13-7. PubMed ID: 17691601 [TBL] [Abstract][Full Text] [Related]
11. Immune responses to South African Babesia canis and the development of a preliminary vaccine. Lewis BD; Penzhorn BL; López Rebollar LM J S Afr Vet Assoc; 1995 Jun; 66(2):61-5. PubMed ID: 8544162 [TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of serodiagnostic assays with recombinant BgSA1 of Babesia gibsoni. Mandal M; Banerjee PS; Kumar S; Garg R; Ram H; Kundu K; Raina OK Vet Parasitol; 2014 Oct; 205(3-4):483-9. PubMed ID: 25241636 [TBL] [Abstract][Full Text] [Related]
13. Vaccination of dogs against Babesia canis infection using parasite antigens from in vitro culture. Schetters TP; Kleuskens J; Scholtes N; Bos HJ Parasite Immunol; 1992 May; 14(3):295-305. PubMed ID: 1625906 [TBL] [Abstract][Full Text] [Related]
14. Soluble parasite antigens from Babesia canis do not directly activate the kallikrein system in dogs infected with Babesia canis. Finizio AL; Kleuskens JA; Van De Crommert J; Gorenflot A; Carcy B; Schetters TP Vet Parasitol; 2011 Mar; 176(2-3):132-8. PubMed ID: 21130577 [TBL] [Abstract][Full Text] [Related]
15. Characterization of the Babesia gibsoni 12-kDa protein as a potential antigen for the serodiagnosis. Goo YK; Jia H; Aboge GO; Terkawi MA; Lee EG; Yamagishi J; Nishikawa Y; Jang HK; Sunaga F; Namikawa K; Fujisaki K; Xuan X Parasitol Int; 2009 Mar; 58(1):55-60. PubMed ID: 19000776 [TBL] [Abstract][Full Text] [Related]
16. Vaccination of dogs against Babesia canis infection. Schetters TP; Kleuskens JA; Scholtes NC; Pasman JW; Goovaerts D Vet Parasitol; 1997 Dec; 73(1-2):35-41. PubMed ID: 9477490 [TBL] [Abstract][Full Text] [Related]
17. Molecular characterization of a novel 32-kDa merozoite antigen of Babesia gibsoni with a better diagnostic performance by enzyme-linked immunosorbent assay. Aboge GO; Jia H; Kuriki K; Zhou J; Nishikawa Y; Igarashi I; Fujisaki K; Suzuki H; Xuan X Parasitology; 2007 Aug; 134(Pt 9):1185-94. PubMed ID: 17381888 [TBL] [Abstract][Full Text] [Related]
18. Characterization and comparison of merozoite antigens of different Babesia canis isolates by serological and immunological investigations. Hauschild S; Shayan P; Schein E Parasitol Res; 1995; 81(8):638-42. PubMed ID: 8570577 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of antibodies against Babesia canis in dogs in an endemic area. Bobade PA; Oduye OO; Aghomo HO Rev Elev Med Vet Pays Trop; 1989; 42(2):211-7. PubMed ID: 2626574 [TBL] [Abstract][Full Text] [Related]
20. Identification and expression of a 50-kilodalton surface antigen of Babesia gibsoni and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay. Fukumoto S; Xuan X; Nishikawa Y; Inoue N; Igarashi I; Nagasawa H; Fujisaki K; Mikami T J Clin Microbiol; 2001 Jul; 39(7):2603-9. PubMed ID: 11427577 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]